AbbVie Affirms Q3 Adj EPS Guidance of $3.84-$3.88 vs $3.84 Est
AbbVie (NYSE:ABBV) affirms Q3 Adj EPS guidance from $3.84-$3.88 to $3.84-$3.88 vs $3.84 analyst estimate..
AbbVie confirmed its earnings prediction for the next three months will match what experts expected—right on target. When a big company sticks to its plan and hits the mark, it shows things are running smoothly and people can trust what the company says.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.